Department of Urology, University of Michigan, Ann Arbor, Michigan, USA.
National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Eur Urol Focus. 2018 Dec;4(6):804-817. doi: 10.1016/j.euf.2017.09.003. Epub 2017 Sep 14.
Over the previous2 decades, there have been numerous advancements in the diagnostic evaluation, therapeutic management, and postoperative assessment of genitourinary malignancies.
To present a review of current and novel imaging modalities and their utility in the assessment of therapeutic response in the systemic management of renal, testicular, and prostate cancers.
A PubMed/Medline search of the current published literature inclusive of prospective and retrospective original research, systematic reviews, and meta-analyses was conducted evaluating imaging modalities for renal cell carcinoma, prostate cancer, and testicular cancer. All relevant literature was individually reviewed and summarized to provide a concise description of the currently available imaging modalities and their efficacy in assessing treatment response of the genitourinary malignancies targeted in this review.
Conventional imaging techniques play a pivotal role in predicting the treatment response of genitourinary malignancies and have, therefore, been incorporated into clinical guidelines. Advancements in imaging technology have led to increased utilization for prognostication of a genitourinary cancer's response to therapy.
A good understanding of current recommended imaging techniques to evaluate treatment response in genitourinary malignancies is of paramount importance for today's clinician, who faces increasing treatment modalities.
In this review, we summarize available imaging modalities in the evaluation of treatment response in kidney, prostate, or testicular tumors. We believe that a good understanding of current imaging modalities is of paramount importance for healthcare providers treating these cancers.
在过去的 20 年中，泌尿系统恶性肿瘤的诊断评估、治疗管理和术后评估取得了许多进展。
介绍当前和新型成像方式及其在评估肾、睾丸和前列腺癌系统治疗中的治疗反应中的应用。
对当前已发表的文献进行了 PubMed/Medline 搜索，包括前瞻性和回顾性原始研究、系统评价和荟萃分析，评估了用于肾细胞癌、前列腺癌和睾丸癌的成像方式。对所有相关文献进行了单独审查和总结，以简明描述当前可用的成像方式及其在评估本综述中靶向的泌尿系统恶性肿瘤治疗反应方面的功效。
传统的成像技术在预测泌尿系统恶性肿瘤的治疗反应方面起着关键作用，因此已被纳入临床指南。成像技术的进步导致其在预测泌尿生殖系统癌症对治疗的反应方面的应用增加。
了解当前推荐的用于评估泌尿系统恶性肿瘤治疗反应的成像技术对当今面临日益增多的治疗方式的临床医生非常重要。
在这篇综述中，我们总结了评估肾、前列腺或睾丸肿瘤治疗反应的现有成像方式。我们认为，了解当前的成像方式非常重要，这对治疗这些癌症的医疗保健提供者来说至关重要。
